Highest-materiality recent filing
Maximus adds $325M term B loans to repurchase stock and repay revolving debt
New Tranche B-1 Term Loans of $325M entered on May 27, 2026; same terms as existing term B loans.
Maximus Q2 EPS beats estimates, raises FY2026 guidance, authorizes $400M buyback
Revenue $1.31B (vs $1.36B YoY); diluted EPS $1.80, adjusted $2.07 (vs $2.01 YoY).
50,864,001 shares (93.2% of outstanding) represented at March 10, 2026 annual meeting.
Maximus Q1 adj EPS $1.85 beats prior $1.61; raises FY2026 guidance
Revenue $1.35B (-4.1% YoY), in-line with expectations; GAAP EPS $1.70 vs $0.69, adj EPS $1.85 vs $1.61.
Maximus Chief Legal Officer John Martinez resigns effective Feb 15, 2026
John T. Martinez, Chief Legal Officer and Corporate Secretary, notified Maximus of his resignation on Dec 15, 2025.
Full year revenue $5.43B (+2.4% YoY); organic growth 3.9% driven by U.S. Federal clinical programs.
Maximus board authorizes $400M stock purchase program expansion
Board increased aggregate authorization to $400M, inclusive of $32.7M remaining under prior program.
Maximus Q3 FY2025 EPS $1.86 ($2.16 adj); raises full-year guidance
Revenue $1.35B (+2.5% YoY); organic growth 4.3% led by U.S. Federal Services (11.4% growth).
Maximus amends bylaws to enhance shareholder proposal disclosure requirements
Shareholders must disclose derivative instruments held within past 24 months and performance-related fees tied to stock value.
Maximus Q2 FY2025: EPS $1.69 (adj. $2.01); raises FY revenue/earnings guidance
Revenue $1.36B (+1.0%); adjusted EPS $2.01 vs $1.57 YoY; organic growth 3.0%.
Maximus adds $250M Tranche A-1 Term Loans to existing credit facility
New Tranche A-1 Term Loans of $250M aggregate principal, same terms as existing term A loans.
Maximus 2025 annual meeting: all directors elected, auditor ratified, say-on-pay approved
All 8 director nominees elected with 48.5M to 49.5M votes for; broker non-votes ~1.66M.
Maximus Q1 revenue up 5.7% to $1.40B, raises FY25 adjusted EPS guidance to $5.90-$6.20
Adjusted diluted EPS $1.61 vs $1.34 YoY; GAAP EPS $0.69 includes $38M divestiture charges from Australia/South Korea sales.
Maximus board authorizes $200M increase to stock purchase program
Previous $200M authorization (June 2024) fully consumed; $171.4M remained as of Sep 30, 2024.
Maximus dismisses EY as auditor, appoints KPMG for FY2025
Audit Committee dismissed Ernst & Young effective Nov 25, 2024, following a competitive selection process.
CMS cancelled the CCO solicitation covering 1-800-MEDICARE and Federal Marketplace; no immediate re-solicitation planned.
Maximus FY2024 revenue up 8.2% to $5.31B; adj. EPS $6.11; FY2025 guidance $5.70-$6.00
Full year FY2024 revenue $5.31B (+8.2% YoY); diluted EPS $4.99; adjusted diluted EPS $6.11.
Maximus Q3 FY2024 revenue $1.31B (+10.6%), adj. EPS $1.74, raises FY guidance for third time
Revenue $1.31B (+10.6% YoY), diluted EPS $1.46, adjusted diluted EPS $1.74 (vs $0.50 and $0.78).
Maximus expands stock buyback program to $200M aggregate
Board authorized $200M stock purchase program, including $6M remaining from prior authorization.
Maximus amends credit agreement, extends maturities and increases revolver to $750M
Tranche A term loans reduced to $650M (from $868.1M), maturity extended to May 2029.
Maximus Q2 revenue up 11.7% to $1.35B, adjusted EPS $1.57; raises FY24 guidance
Revenue $1.35B (+11.7% YoY); organic growth 12.6%; adjusted EPS $1.57 vs $0.81 prior year.
Maximus shareholders elect all eight directors; reject shareholder proposal
All eight director nominees elected with >98% of votes cast in favor; 94.6% of outstanding shares represented.
Maximus announces departure of Teresa Weipert, General Manager U.S. Federal Services
Teresa A. Weipert, General Manager of U.S. Federal Services, departing the company effective February 27, 2024.
Maximus Q1 revenue $1.33B (+6.2%); raises FY24 EPS and FCF guidance
Revenue $1.33B (organic +6.9%); diluted EPS $1.04, adjusted EPS $1.34 vs $0.65/$0.94 YoY.
On February 27, 2024, Maximus, Inc. (the “Company”) announced that Teresa A. Weipert, General Manager, U.S. Federal Services is departing the Company.
Max materiality 0.85 · Median 0.60 · Most common event earnings